Egyptian, Father, Husband, I design and develop #WordPress themes & plugins, founder of @tielabs
Blog.
-
Pfizer is betting big on cancer drugs after Covid decline
Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that bet pays off. Pfizer pitched its deeper push into oncology during a four-hour investor event last week. And it had a splashy 60-second Super Bowl ad…
-
New Activision QA union is the largest in the video game industry
Microsoft CEO Satya Nadella arrives to court in San Francisco on June 28, 2023. Microsoft and Activision Blizzard CEOs are expected to testify to persuade a federal judge in California to reject the Federal Trade Commission’s effort to block their $69 billion deal. Shelby Knowles | Bloomberg | Getty Images A group of roughly 600 software testers at Activision on Friday formed the U.S. video game industry’s largest union so far. The union is the…
-
Hackers use pirated software to hijack Mac, Android and Windows devices
Join Fox News for access to this content Plus special access to select articles and other premium content with your account – free of charge. Please enter a valid email address. By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided. Having trouble? Click here. Trading in…
-
Sam Altman rejoins OpenAI board, company adds three new members
OpenAI on Friday announced its new board and the wrap-up of an internal investigation by U.S. law firm WilmerHale into the events leading up to OpenAI CEO Sam Altman’s ouster. Sam Altman will also rejoin OpenAI’s board. The new board members are: Dr. Sue Desmond-Hellmann, former CEO of the Bill and Melinda Gates Foundation, who is also on the Board of Directors at Pfizer and on the President’s Council of Advisors on Science and Technology.…
-
Novo Nordisk Wegovy approved for cutting heart disease risks
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The Food and Drug Administration on Friday approved Novo Nordisk‘s blockbuster weight loss drug Wegovy for use in slashing the risk of serious cardiovascular complications in adults with obesity and heart disease. Millions of patients already use the popular injectable treatment. But the agency’s decision could widen insurance coverage for the…
Contact me.
[contact-form-7 id=”3642″ title=”Contact form 1″]